ASHP national survey of pharmacy practice in acute care settings: Monitoring, patient education, and wellness—2000

2000 ◽  
Vol 57 (23) ◽  
pp. 2171-2187 ◽  
Author(s):  
Craig A. Pedersen ◽  
Philip J. Schneider ◽  
John P. Santell ◽  
Elizabeth J. Kelly
2000 ◽  
Vol 57 (19) ◽  
pp. 1759-1775 ◽  
Author(s):  
Debra Jones Ringold ◽  
John P. Santell ◽  
Philip J. Schneider

1999 ◽  
Vol 56 (2) ◽  
pp. 142-157 ◽  
Author(s):  
Debra Jones Ringold ◽  
John P. Santell ◽  
Philip J. Schneider ◽  
Steven Arenberg

1997 ◽  
Vol 54 (6) ◽  
pp. 653-669 ◽  
Author(s):  
C. E. Reeder ◽  
Mike Dickson ◽  
Chris M. Kozma ◽  
John P. Santell

Author(s):  
Sujita W Narayan ◽  
Ivo Abraham ◽  
Brian L Erstad ◽  
Curtis E Haas ◽  
Arthur Sanders ◽  
...  

Abstract Purpose Cost-avoidance studies are common in pharmacy practice literature. This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists’ interventions in acute care settings. Methods An Embase and MEDLINE search was conducted to identify studies that estimated cost avoidance from pharmacist interventions in acute care settings. We included studies with human participants and articles published in English from July 2010 to January 2021, with the intent of summarizing the evidence most relevant to contemporary practice. Results The database search retrieved 129 articles, of which 39 were included. Among these publications, less than half (18 of 39) mentioned whether the researchers assigned a probability for the occurrence of a harmful consequence in the absence of an intervention; thus, a 100% probability of a harmful consequence was assumed. Eleven of the 39 articles identified the specific harm that would occur in the absence of intervention. No clear methods of estimating cost avoidance could be identified for 7 studies. Among all 39 included articles, only 1 attributed both a probability to the potential harm and identified the cost specific to that harm. Conclusion Cost-avoidance studies of pharmacists’ interventions in acute care settings over the last decade have common flaws and provide estimates that are likely to be inflated. There is a need for guidance on consistent methodology for such investigations for reporting of results and to confirm the validity of their economic implications.


2010 ◽  
Vol 67 (7) ◽  
pp. 542-558 ◽  
Author(s):  
Craig A. Pedersen ◽  
Philip J. Schneider ◽  
Douglas J. Scheckelhoff

2016 ◽  
Vol 73 (17) ◽  
pp. 1307-1330 ◽  
Author(s):  
Craig A. Pedersen ◽  
Philip J. Schneider ◽  
Douglas J. Scheckelhoff

2007 ◽  
Vol 64 (5) ◽  
pp. 507-520 ◽  
Author(s):  
Craig A. Pedersen ◽  
Philip J. Schneider ◽  
Douglas J. Scheckelhoff

2013 ◽  
Vol 70 (9) ◽  
pp. 787-803 ◽  
Author(s):  
Craig A. Pedersen ◽  
Philip J. Schneider ◽  
Douglas J. Scheckelhoff

2004 ◽  
Vol 61 (5) ◽  
pp. 457-471 ◽  
Author(s):  
Craig A. Pedersen ◽  
Philip J. Schneider ◽  
Douglas J. Scheckelhoff

Sign in / Sign up

Export Citation Format

Share Document